Literature DB >> 8464348

Hypolipidemic effects of beta-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat.

M Riottot1, P Olivier, A Huet, J J Caboche, M Parquet, J Khallou, C Lutton.   

Abstract

The effect of increasing amounts of a cyclic oligosaccharide, beta-cyclodextrin (BCD), included in the diet on plasma cholesterol and triglycerides, was investigated in two animal models, namely in male genetically hypercholesterolemic Rico rats and in male Syrian hamsters. The distribution of bile acids in the gastrointestinal tract and in the feces of hamsters was also determined. In the Rico rats and hamsters, plasma cholesterol and triglycerides decreased linearly with increasing doses of BCD. In these two species, 20% BCD as compared to control diet lowered cholesterolemia (-35%) and triglyceridemia (-70%). In the hamster, the BCD diet caused a marked decrease in cholesterol and triglycerides in chylomicrons and very low density lipoprotein, and in high density lipoproteins cholesterol. Composition and amounts of bile acids were modified in the gastrointestinal tract of hamsters receiving 10% BCD as compared to the control group. The total bile acid content of the gallbladder of treated hamsters was fourfold higher than in the control group, and the bile contained a large amount of hydrophilic bile acids. This trend was also observed in the small intestine, in which percentages and total quantities of cholic plus deoxycholic acids (cholic pathway) were higher than those of chenodeoxycholic plus ursodeoxycholic plus lithocholic acids (chenodeoxycholic pathway). The bile acid contents of the cecum and colon of treated hamsters were 2.7-fold higher than those of control animals, but the bile acid composition was similar in the two groups of hamsters.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464348     DOI: 10.1007/bf02536637

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

1.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

2.  Bile acids and cancer of the large bowel.

Authors:  N F Breuer; H Goebell
Journal:  Dig Dis       Date:  1987       Impact factor: 2.404

3.  Interaction of beta-cyclodextrin with bile salts in aqueous solutions.

Authors:  K Miyajima; M Yokoi; H Komatsu; M Nakagaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-03       Impact factor: 1.645

4.  Metabolism of chenodeoxycholic acid in hamsters.

Authors:  T Tateyama; K Katayama
Journal:  Lipids       Date:  1976-12       Impact factor: 1.880

5.  Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.

Authors:  A Gerlóczy; A Fónagy; P Keresztes; L Perlaky; J Szejtli
Journal:  Arzneimittelforschung       Date:  1985

6.  Effect of citrus pectin on blood lipids and fecal steroid excretion in man.

Authors:  R M Kay; A S Truswell
Journal:  Am J Clin Nutr       Date:  1977-02       Impact factor: 7.045

7.  Guar gum and plasma cholesterol. Effect of guar gum and an oat fiber source on plasma lipoproteins and cholesterol in hypercholesterolemic adults.

Authors:  G A Spiller; J W Farquhar; J E Gates; S F Nichols
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct

8.  Biodynamics of cholesterol and bile acids in the lithiasic hamster.

Authors:  J Khallou; M Riottot; M Parquet; C Verneau; C Lutton
Journal:  Br J Nutr       Date:  1991-11       Impact factor: 3.718

9.  Kinetic difference between hydrolyses of gamma-cyclodextrin by human salivary and pancreatic alpha-amylases.

Authors:  J J Marshall; I Miwa
Journal:  Biochim Biophys Acta       Date:  1981-09-15

10.  Absorption of 7-ketolithocholic acid in rat jejunum, ileum and colon.

Authors:  S Walker; A Stiehl; R Raedsch; P Klöters; B Kommerell
Journal:  Z Gastroenterol       Date:  1985-12       Impact factor: 2.000

View more
  7 in total

Review 1.  Cyclodextrins: their future in drug formulation and delivery.

Authors:  V J Stella; R A Rajewski
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

Review 2.  Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.

Authors:  Baiba K Gillard; Corina Rosales; Bingqing Xu; Antonio M Gotto; Henry J Pownall
Journal:  J Clin Lipidol       Date:  2018-04-12       Impact factor: 4.766

3.  Effect of cyclodextrins and undigested starch on the loss of chenodeoxycholate in the faeces.

Authors:  C Abadie; M Hug; C Kübli; N Gains
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

4.  Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces.

Authors:  Philippe Gérard; Pascale Lepercq; Marion Leclerc; Françoise Gavini; Pierre Raibaud; Catherine Juste
Journal:  Appl Environ Microbiol       Date:  2007-07-06       Impact factor: 4.792

Review 5.  Interactions between cyclodextrins and cellular components: Towards greener medical applications?

Authors:  Loïc Leclercq
Journal:  Beilstein J Org Chem       Date:  2016-12-07       Impact factor: 2.883

Review 6.  Cholesterol in the Cell Membrane-An Emerging Player in Atherogenesis.

Authors:  Karel Paukner; Ivana Králová Lesná; Rudolf Poledne
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

7.  Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.

Authors:  Yoram Bouhnik; Lotfi Achour; Damien Paineau; Michel Riottot; Alain Attar; Francis Bornet
Journal:  Nutr J       Date:  2007-12-05       Impact factor: 3.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.